alexa Killing Methicillin-resistant Staphylococcus Aureus (MRSA US300) By Myxoamoeba | 15204
ISSN: 2155-9597

Journal of Bacteriology & Parasitology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

International Congress on Bacteriology & Infectious Diseases

Marcin Filutowicz
Accepted Abstracts: J Bacteriol Parasitol
DOI: 10.4172/2155-9597.S1.004
Abstract
Physicians and the general public often associate microorganisms solely with disease and antibiotic treatment. But contrary to that notion, most microbes are benign or beneficial to humans. Only recently have scientists begun to recognize the value of exploiting microbes, and their millions of years of evolution, to control bacteria. Against a background of failing antibiotics and the emergence of new pathogens, certain microorganisms have the potential to be developed into biocontrol agents. In this presentation, we will discuss a new biologically based treatment for wound infections. These wounds present a substantial burden both in terms of individual and societal costs. For the patient, this type of wound too often does not heal, requires ongoing medical interventions, delays recovery, or can even cause death. Faced with treatment failures and incurred complications, clinicians are desperate for better methods to reduce the ?infective bacterial load,? which is known to be a principal determining factor in wound healing. One potentially promising treatment involves the use of nonpathogenic myxoamoebae. As single-celled organisms, they hunt and efficiently devour a wide variety of bacteria, including S. aureus (MRSA US300). Notably, amoebae exhibit characteristics similar to macrophages and neutrophils; they all indiscriminately chase, engulf and digest their microbial prey. Furthermore, because amoebae thrive within biologically complex and environmentally harsh soil bio-webs, it is likely they can access bacteria within biofilms. Thus, myxoamoebae may succeed where chemical antibiotics are failing in the control of drug resistant pathogens including those that form biofilms.
Biography
Marcin Filutowicz has completed his Ph.D. at the Institute of Biochemistry and Biophysics, Polish Academy of Sciences in Warsaw, Poland, and postdoctoral studies from University of California San Diego. He is a Professor of Bacteriology at UW Madison. Throughout his career MF translated a basic research carried out in his academic laboratory into the technology platforms exploring a novel means to control the rising tide of infections by antibiotic-resistant bacteria. In 2001, he founded ConjuGon Inc., a corporation developing novel technologies for using benign bacteria as drugs. In 2010 MF founded AmebaGone, LLC. The company uses myxoamoebae, as antimicrobials in agriculture, medicine and industry.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7